BiomX Inc. (PHGE)

BiomX Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	9.69	8.65	9.46	11.27	9.32	8.72
Research & Development	16.24	16.7	16.24	22.68	19.42	13.49
Other Operating Expenses	0	0	1.52	1.52	1.52	0
Operating Expenses	25.93	25.35	27.22	35.46	30.26	22.21
Operating Income	-25.93	-25.35	-27.22	-35.46	-30.26	-22.21
Interest Expense / Income	2.69	2.4	2.07	0.7	0	0
Other Expense / Income	8.5	-1.61	-1.04	-0	-0.17	-1.64
Pretax Income	-37.11	-26.15	-28.25	-36.16	-30.09	-20.56
Income Tax	0.02	0.02	0.07	0.07	0	0
Net Income	-37.14	-26.17	-28.32	-36.23	-30.09	-20.56
Shares Outstanding (Basic)	62	51	30	26	23	6
Shares Outstanding (Diluted)	62	51	30	26	23	6
Shares Change	93.90%	71.94%	14.79%	12.77%	310.66%	180.45%
EPS (Basic)	-0.61	-0.51	-0.95	-1.39	-1.30	-3.66
EPS (Diluted)	-0.61	-0.51	-0.95	-1.39	-1.30	-3.66
Free Cash Flow	-27.64	-21.34	-29.2	-31.25	-25.46	-18.89
Free Cash Flow Per Share	-0.44	-0.42	-0.98	-1.20	-1.10	-3.36
EBITDA	-33.55	-22.87	-23.66	-32.9	-27.91	-20.25
Depreciation & Amortization	0.88	0.87	2.52	2.57	2.18	0.32
EBIT	-34.42	-23.74	-26.18	-35.46	-30.09	-20.56

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).